The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Navigating the clinical trial maze: Identifying barriers to enrollment among patients with advanced cancer in a community-academic partnership.
 
Aakash Desai
Consulting or Advisory Role - Amgen; AstraZeneca; Foundation Medicine; Janssen Oncology; Sanofi
 
Madhan Srinivasan Kumar
No Relationships to Disclose
 
Tiffany Huggins
No Relationships to Disclose
 
Ellen McNeeley
No Relationships to Disclose
 
Nusrat Jahan
No Relationships to Disclose
 
Furhan Yunus
Honoraria - Genentech
Research Funding - Genentech
 
Maya Khalil
Research Funding - Abbvie (Inst); Advenchen Laboratories (Inst); Amgen (Inst); Arcus Biosciences (Inst); Artios (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb Company (Inst); Cantargia AB (Inst); Caris Life Sciences (Inst); DynamiCure Biotechnology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Henlius (Inst); Henlius (Inst); Janssen (Inst); Johnson & Johnson/Janssen (Inst); Kronos (Inst); Lilly (Inst); Loxo/Lilly (Inst); Lucence (Inst); Merck (Inst); National Cancer Institute (Inst); NGM Biopharmaceuticals (Inst); Nitto BioPharma (Inst); Numab (Inst); Orum Therapeutics (Inst); Relay Therapeutics (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst); Xencor (Inst); Xencor (Inst)
 
Jan Ole Kemnade
No Relationships to Disclose
 
Bassel F. El-Rayes
Honoraria - Charles River Associates
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Exelixis; Genentech; QED Therapeutics; QED Therapeutics; Seagen; Stemline Therapeutics; Taiho Oncology; Taiho Oncology
Speakers' Bureau - Intellisphere
Research Funding - Adaptimmune (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); IQvia (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Wayne State University (Inst); Xencor (Inst); Zymeworks (Inst)
Other Relationship - ERYTECH Pharma; Exelixis; SC Liver Research Consortium
 
Mehmet Akce
Consulting or Advisory Role - AstraZeneca; Curio Science; Eisai; Eisai; Eisai; Eisai; Exelixis; Genentech; GlaxoSmithKline; Incyte; Ipsen; Isofol Medical; QED Therapeutics; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Eisai (Inst); IMPAC Medical Systems (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Polaris (Inst); RedHill Biopharma (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst); Xencor (Inst)
 
Rebecca Christian Arend
Employment - Signatera (I)
Consulting or Advisory Role - Caris Life Sciences; GlaxoSmithKline; KIYATEC; Leap Therapeutics; Merck; Seagan; Sutro Biopharma; VBL Therapeutics
Research Funding - Champions Oncology; Exelixis; GlaxoSmithKline; Immunogen; Merck
Travel, Accommodations, Expenses - Caris Life Sciences; GlaxoSmithKline; VBL Therapeutics